Finance

Beta
Ask
Lists
51S:FRA
Cynata Therapeutics Ltd
€0.14
0.00%
(0.00) 1D
Jun 11, 8:04:16 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 51S...
Mkt. cap
63.30M
Avg. vol.
1.16K
Volume
0.00
52-wk high
€0.24
52-wk low
€0.06
No. of employees
0
Mkt. cap
63.30M
Avg. vol.
1.16K
Volume
0.00
52-wk high
€0.24
52-wk low
€0.06
No. of employees
0
News stories
From sources across the web
About Cynata Therapeutics Ltd
CEORoss Alexander Macdonald
Employees0
Founded2003
Headquarters-
SectorBiotechnology
Websitecynata.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-42.49K
-42.49K
886.14K
886.14K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.70M
3.70M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-1.17M
-1.17M
1.69M
1.69M
Operating expense
2.94M
2.94M
2.22M
2.22M
Total operating expenses
2.94M
2.94M
2.22M
2.22M
Operating income
-2.98M
-2.98M
-1.33M
-1.33M
Other non operating income
-
-
-
-
EBT including unusual items
-2.87M
-2.87M
-1.33M
-1.33M
EBT excluding unusual items
-2.87M
-2.87M
-1.33M
-1.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
278.28K
278.28K
425.31K
425.31K
Net income
-2.87M
-2.87M
-1.33M
-1.33M
Net profit margin
6,754.99%
6,754.99%
-150.23%
-150.23%
Earnings per share
-
-
-
-
Interest and investment income
113.85K
113.85K
-
-
Interest expense
-
-
-
-
Net interest expenses
113.85K
113.85K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.91M
-2.91M
-1.27M
-1.27M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer